You have read all your free articles, to continue reading subscribe to read the rest of this content.
AstraZeneca today announced that MedImmune, its global biologics research and development arm, has entered into a licensing agreement with Allergan plc for the global rights to MEDI2070. MEDI2070 is an IL-23 monoclonal antibody currently in a Phase IIb clinical trial for moderate-to-severe CrohnâAlready a subscriber Login You have read all…
According to a new analysis from RAND Corp, introducing biosimilar versions of complex biologic drugs could cut healthcare spending in the US by $54 billion over the next decade. The savings estimate is about 20 percent larger than a similar analysis done by RAND researchers three years ago, reprAlready a…
The drug development consultancy announces the opening of a Paris office to serve its increasing French customer base and in continuation of its strategic global expansion. This is NDA’s fifth European location, having offices in Stockholm, London, Munich and Zürich. The Paris office will compAlready a subscriber Login You have…
The European Commission (EC) has extended the marketing authorization for the company’s smallpox vaccine, IMVANEX to include protection from monkeypox and disease caused by vaccinia virus. The approval, which follows a positive opinion by the Committee for Medicinal Products for Human Use (CHMPAlready a subscriber Login You have read all…
